Becton Dickinson & Co (BDX) Reports Q1 Fiscal 2024 Results: Margin Execution Leads to ...

BDX Sees Organic Revenue Growth and Raises Full-Year Adjusted EPS Guidance

Related Keywords

Tom Polen ,Bd Life Sciences ,Medication Management Solutions ,Becton Dickinson Co ,Revenue Growth ,Pharmaceutical Systems ,Critical Care ,Integrated Diagnostic Solutions ,Becton Dickinson ,Revenue Increase ,Q1 Revenue ,